General Information of Drug (ID: DMZ422P)

Drug Name
IMM-124E
Indication
Disease Entry ICD 11 Status REF
Non-alcoholic fatty liver disease DB92 Phase 2 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
DMN03O

References

1 ClinicalTrials.gov (NCT02316717) A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis. U.S. National Institutes of Health.